Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
3.760
-0.060 (-1.57%)
Nov 9, 2026, 9:42 AM EST - Market open
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Vanda Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $11.5. The average 1-year stock price forecast is 205.85% higher than the current stock price, while the lowest is $4.50 (+19.68%) and the highest is $20 (+431.91%).
Price Target: $11.5 (+205.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +431.91% | Nov 2, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $12 | Buy | Maintains | $12 | +219.15% | Oct 29, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 | Buy | Maintains | $11 | +192.55% | Oct 29, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +165.96% | Sep 23, 2026 |
Financial Forecast
Revenue This Year
242.14M
from 216.11M
Increased by 12.05%
Revenue Next Year
316.26M
from 242.14M
Increased by 30.61%
EPS This Year
0.96
EPS Next Year
1.04
from 0.96
Increased by 8.33%
EPS and Forward PE are based on non-GAAP adjusted numbers.